Councillor for IU-Greens in the City Sewer, Carmen Maria Pina, has filed a motion to Parliament next Thursday seeking greater engagement and involvement of the local authority in the fight against hepatitis C.
The initiative calls for the council to urge the Central Government to make the necessary arrangements for the issuance of compulsory license antiviral medication Sofosbuvir and authorize the supply of this product by manufacturing generic, establishing a sustainable price to the public purse.
It also requires the Executive's Office to withdraw his resignation to the import of generic produced under compulsory license in third countries to import drugs if generic production under compulsory license held in Spain is not sufficient.
IU-Green has also called for the establishment of private patents on products that are developed as part of research funded by public institutions is prohibited.
According to Pina, the price of treatment Sofosbuvir marketed by Gilead pharmaceutical and whose effectiveness in eradicating hepatitis C has been demonstrated, is "very unfair" and is necessary for the central government to intervene to cover people suffering that disease.